In 2014, the Schizophrenia Working Group of the Psychiatric Genomics Consortium (PGC) reported a multi-stage schizophrenia genome-wide association study (PGC2 GWAS) of up to 36,989 cases and 113,075 controls. They identified 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance (Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510):421-427. [PMID: 25056061]). The Tagged genes in these loci were collected into this database as PGC2 GWAS genes.
    In 2018, Pardiñas et al. reported a new genome-wide association study of schizophrenia (CLOZUK GWAS; 11,260 cases and 24,542 controls), and through meta-analysis with independent PGC datasets they identified 50 novel associated loci and 145 loci in total associated with schizophrenia (Pardiñas et al. 2018. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nature Genetics, 50(3):381-389. [PMID: 29483656]). The Tagged genes in these loci were collected into this database as CLOZUK GWAS genes.
    It should be noted that these two GWAS studies were not fully independent.
    If you used this data, please cite the reletive reference.